C HEALTH GP (08225) released its interim performance. The shareholders' attributable profit increased by 18.31% year-on-year to 8.699 million yuan.
China Medical Group (08225) announced its interim performance for the six months ending June 30, 2025, with operating income of 2.5...
C HEALTH GP (08225) announced its interim performance for the six months ended June 30, 2025, with operating revenue of 21.62 million yuan (RMB, the same below), an increase of 18.19% year-on-year; net profit attributable to shareholders was 8.699 million yuan, an increase of 18.31% year-on-year; basic earnings per share were 0.87 cents.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
